The results also demonstrated that CBX7 high mRNA expression was significantly correlated to longer RFS in patients who have received adjuvant chemotherapy only (HR=0.7, p=0.023) (Figure 6H), indicating a potential role of CBX7 in contribution to chemosensitivity in breast cancer. This evidence concerns the gene CBX7 and breast carcinoma.